Related Posts



You are about to leave Risk Strategies website and view the content of an external website.
You are leaving risk-strategies.com
By accessing this link, you will be leaving Risk Strategies website and entering a website hosted by another party. Please be advised that you will no longer be subject to, or under the protection of, the privacy and security policies of Risk Strategies website. We encourage you to read and evaluate the privacy and security policies of the site you are entering, which may be different than those of Risk Strategies.
Summary: Spring is officially here, and with a new season comes a new compliance deadline looming for employers sponsoring group health plans: RxDC reporting for the 2024 reference year.
The Centers for Medicare and Medicaid Services (CMS) recently released updated RxDC reporting instructions for the 2024 reference year, which is due on June 1, 2025.
The updated instructions confirm no changes from the previous version of RxDC reporting instructions other than updating the reference year from 2023 to 2024.
Read on for a general overview of RxDC reporting and plan sponsor considerations ahead of the June 1, 2025 deadline.
The CAA, passed by Congress in December 2020, included a requirement for group health plans (and health insurers) to submit detailed prescription drug pricing and healthcare spending data to CMS, aimed at increasing transparency in prescription drug and health care spending.
This data, referred to as “Prescription Drug Data Collection” or the RxDC report, is collected and aggregated by CMS[1], which in turn publishes public reports on prescription drug spending and pricing, along with spending on health care services and premium paid by members and employers. The “Prescription Drug Spending, Pricing Trends and Premiums in Private Health Insurance Plans” report, accessed here, was published for the first time in November 2024.[2]
Many employer group health plan sponsors relied on their reporting entity vendors, such as plan carriers, third-party administrators (TPAs), and/or pharmacy benefit managers (PBMs), to submit the required RxDC reporting data to CMS for the prior year deadlines, which began in 2022.
These reporting entity vendors compile and maintain the required data on behalf of the plans and are in the best position to complete the technical requirements for RxDC reporting. Group health plan sponsors should continue this approach for their RxDC reporting for the 2024 reference year as the June 1, 2025 deadline approaches.
The table below captures which health plans are required to submit RxDC reporting to CMS:
Type of Health Plan |
Required to Submit RxDC Report? (Yes/No) |
ERISA group health plans[3] including:
|
Yes |
Non-federal governmental plans, such as plans sponsored by state and local government |
Yes |
Church plans subject to the Internal Revenue Code |
Yes |
Individual health coverage plans including:
|
Yes |
Health Reimbursement Arrangements (HRAs) and other account-based plans. |
No |
Excepted benefits including, but not limited to:
|
No |
Retiree-only plans |
No |
Medicare and Medicaid plans |
No |
Plans maintained outside of the U.S. primarily for the benefit of persons substantially all of whom are nonresident aliens. |
No |
The RxDC reports are required to include the following information:
While the updated RxDC reporting instructions do not contain any changes from the previous year's instructions, the items below are included as helpful practical tips and reminders for employers to complete this plan compliance requirement:
Example: A self-funded group health plan may contract with a TPA to submit the Spending by Category data file (D2) and separately contract with a PBM to submit the Top 50 Most Costly Drugs file (D4). The submission for a plan is considered complete if CMS receives all required files, regardless of who submits the files.
Plan year is July 1, 2023 through June 30, 2024:
Illustrative Example: Non-calendar year plan in the 2024 RxDC report.
Group Health Plan Name |
Group Health Plan Number |
Market Segment |
Plan Year Beginning Date |
Plan Year End Date |
Members as of 12/31 of the reference year |
Employer X’s Health & Welfare Plan |
501 |
Small group market |
07/01/2023 |
6/30/2024 |
0 |
Employer X’s Health & Welfare Plan |
501 |
Small group market |
07/01/2024 |
6/30/2025 |
27 |
As the June 1, 2025 deadline approaches for the 2024 reference year RxDC reporting, many reporting entity vendors have already reached out to plan sponsor employers with requests for required information to complete the required data fields. Employers are advised to take note of the upcoming deadline and promptly respond to vendor requests with the required information to ensure timely completion and submission of their 2024 reference year RxDC reporting.
As a reminder for those employers whose plan vendors will not submit all of the required RxDC reporting data on their behalf, they will need to register directly through the CMS reporting module called Health Insurance Oversight System (HIOS) to submit the required data. Instructions on how to create an account in the HIOS module can be accessed here. Click here for CMS-issued guidance and resource materials with detailed information on the RxDC reporting process, including an FAQs document. Since the HIOS registration process can take some time, employer plan sponsors who must report data directly to CMS are advised to begin the HIOS registration process as soon as possible to avoid unnecessary reporting delays and issues around password resets, account access, and/or error messages.
Risk Strategies is here to help. Reach out to your Risk Strategies account team for additional questions or contact us directly here.
[1] CMS collects the RxDC report on behalf of the Departments of Health and Human Services, the Department of Labor, the Department of Treasury, and the Office of Personnel Management.
[2] This report analyzes RxDC reporting data for 2020 and 2021. Data for 2022, submitted by June 1, 2023, will be analyzed in the next biannual report to Congress.
[3] Including grandfathered and grandmothered group health plans.
The contents of this article are for general informational purposes only and Risk Strategies Company makes no representation or warranty of any kind, express or implied, regarding the accuracy or completeness of any information contained herein. Any recommendations contained herein are intended to provide insight based on currently available information for consideration and should be vetted against applicable legal and business needs before application to a specific client.